リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Comprehensive Investigations of Multiple Factors That Are Related to Refractory Outcome in Urosepsis Patients」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Comprehensive Investigations of Multiple Factors That Are Related to Refractory Outcome in Urosepsis Patients

Sejima Takehiro 眞砂 俊彦 森實 修一 本田 正史 武中 篤 鳥取大学 DOI:10.33160/yam.2022.08.012

2022.08.29

概要

Background
Urosepsis is an acute life-threating disease, and some cases show refractory outcome to therapy. In an aging society of developed countries, characteristics of urosepsis are becoming complicated. We performed a comprehensive investigation regarding the clinical and social aspects that are related to refrac- tory outcomes in urosepsis patients.

Methods
The patient cohort consisted of 66 patients with urosepsis. Multiple factors from clinical and social aspects were reviewed retrospectively. Two categories of refractory outcomes were defined. One was afebrile resistance (AR); fever continued more than 7 days from the initiation of therapy. Another was discharge resistance (DR); hospitalization continued for more than 30 days. Logistic regression analyses were performed to identify significant factors that are related to the AR or DR.

Results
Univariate analysis demonstrated that high score of Eastern Cooperative Oncology Group Performance Status (ECOG PS) (≥ 2) and Age-adjusted Charlson comorbidity index (CCI) (≥ 4), high serum C-reactive protein (CRP) level (≥ 14.9 mg/dL), and low serum albumin level (≤ 2.26 g/dL) were significantly related to AR. Univariate analysis results also revealed that high score of ECOG PS (≥ 2), high serum creatinine level (≥ 1.54 mg/dL) and vasopressor administration were significantly related to DR. Multivariate analyses demonstrated that low serum albumin level (≤ 2.26g/dL) was the only significant factor that was related to AR. In contrast, high score of ECOG PS (≥ 2) and high serum creatinine level (≥ 1.54 mg/dL) were significant factors that were related to DR.

Conclusion
It is suggested that evaluating serum albumin levels is essential for the therapeutic first step because hypoalbuminemia was the significant factor that was related to obstruction to antipyresis. It is also suggested that the deterioration of patients’ activities of daily living and renal dysfunction might be the refrac- tory factors for discharge from the hospital, which was the ultimate therapeutic goal.

Key words
sepsis; urinary tract infection; urosepsis

論文の公開元へ

関連論文

関連論文をもっと見る

参考文献

1 Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801-10. DOI: 10.1001/jama.2016.0287, PMID:26903338

2 Sartelli M, Kluger Y, Ansaloni L, Hardcastle TC, Rello J, Watkins RR, et al. Raising concerns about the Sepsis-3 defi- nitions. World J Emerg Surg. 2018;13:6. DOI: 10.1186/s13017- 018-0165-6, PMID: 29416555

3 Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, et al.; Academic Medical Center Consortium Sep- sis Project Working Group. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA. 1997;278:234-40. DOI: 10.1001/jama.1997.03550030074038, PMID: 9218672

4 Wichmann MW, Inthorn D, Andress HJ, Schildberg FW. Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med. 2000;26:167-72. DOI: 10.1007/s001340050041, PMID: 10784304

5 Wagenlehner FM, Lichtenstern C, Rolfes C, Mayer K, Uhle F, Weidner W, et al. Diagnosis and management for urosepsis. Int J Urol. 2013;20:963-70. PMID: 23714209

6 Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, Osborn T, et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012;12:919-24. DOI: 10.1016/ S1473-3099(12)70239-6, PMID: 23103175Investigation relating to refractory outcomes

7 Bahagon Y, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM. Prevalence and predictive features of bacteremic urinary tract infection in emergency department patients. Eur J Clin Microbiol Infect Dis. 2007;26:349-52. DOI: 10.1007/s10096- 007-0287-3, PMID: 17431694

8 Elhanan G, Sarhat M, Raz R. Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteraemia due to urinary tract infection. J Infect. 1997;35:283-8. DOI: 10.1016/ S0163-4453(97)93194-7, PMID: 9459403

9 Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649-56. DOI: 10.1097/00000421-198212000-00014,PMID: 7165009

10 Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitu- dinal studies: development and validation. J Chronic Dis. 1987;40:373-83. DOI: 10.1016/0021-9681(87)90171-8, PMID:3558716

11 Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Trans- plant. 2013;48:452-8. DOI: 10.1038/bmt.2012.244, PMID: 23208313

12 Kino M, Hayashi T, Hino D, Nakada T, Kitoh H, Akakura K. Patients’ poor performance status is an independent risk factor for urosepsis induced by kidney and ureteral stones. Urolithiasis. 2021;49:477-84. DOI: 10.1007/s00240-021- 01256-4, PMID: 33755744

13 Chugh S, Pietropaolo A, Montanari E, Sarica K, Somani BK. Predictors of Urinary Infections and Urosepsis After Ure- teroscopy for Stone Disease: a Systematic Review from EAU Section of Urolithiasis (EULIS). Curr Urol Rep. 2020;21:16. DOI: 10.1007/s11934-020-0969-2, PMID: 32211969

14 Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol. 2005;45:1563-9. DOI: 10.1016/j.jacc.2004.12.077, PMID: 15893167

15 Thiele JR, Zeller J, Bannasch H, Stark GB, Peter K, Eisenhardt SU. Targeting C-Reactive Protein in Inflammatory Disease by Preventing Conformational Changes. Mediators Inflamm. 2015;2015:1-9. DOI: 10.1155/2015/372432, PMID: 26089599

16 Sproston NR, Ashworth JJ. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front Immunol. 2018;9:754. DOI: 10.3389/fimmu.2018.00754, PMID: 29706967

17 Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: Pathogenesis and Clinical Significance. JPEN J Parenter Enteral Nutr. 2019;43:181-93. DOI: 10.1002/jpen.1451, PMID: 30288759

18 Herrmann FR, Safran C, Levkoff SE, Minaker KL. Serum albumin level on admission as a predictor of death, length of stay, and readmission. Arch Intern Med. 1992;152:125-30. DOI: 10.1001/archinte.1992.00400130135017, PMID:1728907

19 Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth. 2000;85:599-610. DOI: 10.1093/bja/85.4.599, PMID: 11064620

20 Ballmer PE. Causes and mechanisms of hypoalbuminaemia. Clin Nutr. 2001;20:271-3. DOI: 10.1054/clnu.2001.0439, PMID: 11407876

21 Ballmer PE, Ochsenbein AF, Schütz-Hofmann S. Trans- capillary escape rate of albumin positively correlates with plasma albumin concentration in acute but not in chronic inflammatory disease. Metabolism. 1994;43:697-705. DOI: 10.1016/0026-0495(94)90117-1, PMID: 7515458

22 Godinez-Vidal AR, Correa-Montoya A, Enríquez-Santos D, Pérez-Escobedo SU, López-Romero SC, Gracida-Mancilla NI. Is albumin a predictor of severity and mortality in patients with abdominal sepsis? Cir Cir. 2019;87:485-9. PMID: 31448796

23 Artero A, Zaragoza R, Camarena JJ, Sancho S, González R, Nogueira JM. Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock. J Crit Care. 2010;25:276-81. DOI: 10.1016/j.jcrc.2009.12.004, PMID: 20149587

24 Seo MH, Choa M, You JS, Lee HS, Hong JH, Park YS, et al. Hypoalbuminemia, Low Base Excess Values, and Tachypnea Predict 28-Day Mortality in Severe Sepsis and Septic Shock Patients in the Emergency Department. Yonsei Med J. 2016;57:1361-9. DOI: 10.3349/ymj.2016.57.6.1361, PMID:27593863

25 Permpikul C, Sivakorn C, Tongyoo S. In-Hospital Death after Septic Shock Reversal: A Retrospective Analysis of In- Hospital Death among Septic Shock Survivors at Thailand’s Largest National Tertiary Referral Center. Am J Trop Med Hyg. 2021;104:395-402. DOI: 10.4269/ajtmh.20-0896, PMID: 33146115

26 Melia D, Post B. Human albumin solutions in intensive care: A review. J Intensive Care Soc. 2021;22:248-54. DOI: 10.1177/1751143720961245, PMID: 34422108

27 Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, et al.; ALBIOS Study Investigators. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370:1412-21. DOI: 10.1056/NEJ- Moa1305727, PMID: 24635772

28 SAFE Study Investigators. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med. 2011;37:86-96. DOI: 10.1007/ s00134-010-2039-6

29 Charpentier J, Mira J; EARSS Study Group. efficacy and tolerance of hyperoncotic albumin administration in septic shock patients: the EARSS study [abstract]. Intensive Care Med. 2011;37(suppl 2):1.

30 Hoste EAJ, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in criti- cally ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411-23. DOI: 10.1007/s00134-015-3934-7, PMID: 26162677

31 Mehta RL, Cerdá J, Burdmann EA, Tonelli M, García-García G, Jha V, et al. International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet. 2015;385:2616-43. DOI: 10.1016/S0140-6736(15)60126-X,PMID: 25777661

32 Quenot JP, Binquet C, Kara F, Martinet O, Ganster F, Navellou JC, et al. The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study. Crit Care. 2013;17:R65. DOI: 10.1186/cc12598, PMID: 23561510

参考文献をもっと見る